PI3K/AKT PATHWAY IS INVOLVED IN MDS PATHOGENESIS AND MAY CONSTITUTE A POTENTIAL THERAPEUTIC TARGET

被引：0
|
作者：
Rezende, D. C. [1 ]
Pacheco, L. Z. [1 ]
Pelloso, L. A. F. [1 ]
Chauffaille, M. L. L. F. [1 ]
Yamamoto, Y. [1 ]
Silva, M. [2 ]
Kerbauy, D. B. [1 ]
机构：
[1] UNIFESP EPM, Sao Paulo, Brazil
[2] HSPE FMO, Serv Hematol, Sao Paulo, Brazil
来源：
EXPERIMENTAL HEMATOLOGY | 2010年 / 38卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
174
引用
收藏
页码：S82 / S82
页数：1
相关论文
共 50 条
  • [41] The PI3K/mTOR pathway is a potential therapeutic target in cancers with ARID1A mutations
    Kwan, Suet-Yan
    Izaguirre, Daisy I.
    Cheng, Xuanjin
    Kwan, Suet-Ying
    Tsang, Yvonne T. M.
    Kwan, Hoi-Shan
    Wong, Kwong-Kwok
    CANCER RESEARCH, 2015, 75
  • [42] Roles of PI3K/AKT/GSK3 Pathway Involved in Psychiatric Illnesses
    Matsuda, Satoru
    Ikeda, Yuka
    Murakami, Mutsumi
    Nakagawa, Yukie
    Tsuji, Ai
    Kitagishi, Yasuko
    DISEASES, 2019, 7 (01)
  • [43] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70
  • [44] PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy
    Fattahi, Soheila
    Khalifehzadeh-Esfahani, Zahra
    Mohammad-Rezaei, Mina
    Mafi, Sahar
    Jafarinia, Morteza
    IMMUNOLOGIC RESEARCH, 2022, 70 (03) : 269 - 275
  • [45] PI3K/AKT/MTOR PATHWAY AS A POTENTIAL TARGET FOR VULVAR SQUAMOUS CELL CARCINOMA TREATMENT.
    Kowalewska, M.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 1239 - 1239
  • [46] PI3K/Akt/mTOR pathway: a potential target for anti-SARS-CoV-2 therapy
    Soheila Fattahi
    Zahra Khalifehzadeh-Esfahani
    Mina Mohammad-Rezaei
    Sahar Mafi
    Morteza Jafarinia
    Immunologic Research, 2022, 70 : 269 - 275
  • [47] Assessing the therapeutic potential of Elephantopus scaber extract in hepatocellular carcinoma by inhibiting the PI3K/Akt pathway
    Gong, Rui-Hong
    Chen, Jia-Wen
    Shen, Li-Sha
    Lin, Yu-Shan
    Yu, Haiyang
    Chen, Sibao
    Chen, Guo-Qing
    JOURNAL OF FUNCTIONAL FOODS, 2024, 113
  • [48] PI3K PATHWAY PROVIDES A NOVEL THERAPEUTIC TARGET FOR PAEDIATRIC EPENDYMOMA
    Rogers, Hazel
    Chapman, Rebecca
    Mayne, Cerys
    Duane, Holly
    Kilday, John-Paul
    Coyle, Beth
    Grundy, Richard
    NEURO-ONCOLOGY, 2014, 16 : 21 - 21
  • [49] PI3KΔ PATHWAY A NOVEL THERAPEUTIC TARGET FOR SJOGREN'S SYNDROME
    Nayar, S.
    Campos, J.
    Buckley, C.
    Allen, R. A.
    Fahy, W. A.
    Payne, A.
    Barone, F.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 793 - 794
  • [50] A Review: PI3K/AKT/mTOR Signaling Pathway and Its Regulated Eukaryotic Translation Initiation Factors May Be a Potential Therapeutic Target in Esophageal Squamous Cell Carcinoma
    Huang, Ran
    Dai, Qiong
    Yang, Ruixue
    Duan, Yi
    Zhao, Qi
    Haybaeck, Johannes
    Yang, Zhihui
    FRONTIERS IN ONCOLOGY, 2022, 12
12345